Coverage
-
August 03, 2012
The Judicial Panel for Multidistrict Litigation on Thursday declined to centralize in Illinois seven class actions accusing GlaxoSmithKline LLC, Pfizer Inc. and seven other major drugmakers of racketeering and antitrust violations for allegedly subsidizing illegal co-payments for brand-name prescription drugs.
1 other articles on this case.
View all »